In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of tamping down prescription drug costs. The new law targets pharmacy benefit ...

The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...

The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...

In 2025, everyone enrolled in Part D will have their annual out-of-pocket drug costs capped at $2,000. In future years, that cap will rise in step with the rate of change in Part D costs.

The Federal Trade Commission said on Friday that it had taken legal action against the three largest pharmacy benefit ...

The agency says the companies artificially inflated insulin list prices that resulted in patients paying more for the medications. The companies are CVS Health’s Caremark RX, Cigna’s Express Scripts, ...

The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...

The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in ...

FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...